BioWorld Today: News to Note--Flamel Technologies Inc.

May 11, 2013 - BioWorld Today

Flamel Technologies Inc., of Lyon, France, said it exercised its right to regain control of two drugs that use its Trigger lock delivery technology that formerly were being developed in partnership with an undisclosed partner. Trigger Lock is an abuse-resistant technology for longacting opioid analgesics. Flamel said it intends to advance development of those products, either internally or with a new partner, and will determine a path forward after completing a review of the data.